Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Johnson & …
Health Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Johnson & …
Senju Pharma has launched a new drug for dry eye disease (DED) in Japan, Avarept, which is the first drug …
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. AI has …
Japanese pharma group Otsuka has agreed to acquire Transcend Therapeutics and its MDMA-based drug candidate for post-traumatic stress disorder (PTSD) …
After launching a PrEP medication that was 100% effective in clinical trials, the company is facing a complex global rollout …
This week saw both Regenxbio and Solid Bio report new data with their gene therapy candidates for Duchenne muscular dystrophy …
Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. CEO departures …
A report from Genetic Alliance UK has claimed that the NHS is failing to meet the needs of many of …
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Merck & …
Investor panic has poleaxed Quince Therapeutics share price, after a regulatory filing revealed the biotech’s cash is running out and …
Health-Newswire.Net™ aggregates, publishes and distributed news about the Healthcare industry. In association with EmailWire, Health-Newswire.Net™ provides press release distribution services in the Healthcare sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:
Health Newswire™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC